Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

CXCL5 stimulation of RANK ligand expression in Paget's disease of bone.

Sundaram K, Rao DS, Ries WL, Reddy SV.

Lab Invest. 2013 Apr;93(4):472-9. doi: 10.1038/labinvest.2013.5. Epub 2013 Feb 25.

2.

SOCS-1/3 participation in FGF-2 signaling to modulate RANK ligand expression in paget's disease of bone.

Sundaram K, Senn J, Reddy SV.

J Cell Biochem. 2013 Sep;114(9):2032-8. doi: 10.1002/jcb.24554.

PMID:
23553658
3.

FGF-2 stimulation of RANK ligand expression in Paget's disease of bone.

Sundaram K, Senn J, Yuvaraj S, Rao DS, Reddy SV.

Mol Endocrinol. 2009 Sep;23(9):1445-54. doi: 10.1210/me.2009-0078. Epub 2009 Jun 25.

4.

Functional role for heat shock factors in the transcriptional regulation of human RANK ligand gene expression in stromal/osteoblast cells.

Roccisana JL, Kawanabe N, Kajiya H, Koide M, Roodman GD, Reddy SV.

J Biol Chem. 2004 Mar 12;279(11):10500-7. Epub 2003 Dec 29.

5.

Elevated serum kininogen in patients with Paget's disease of bone: a role in marrow stromal/preosteoblast cell proliferation.

Tsuruga E, Rao DS, Baatz JE, Reddy SV.

J Cell Biochem. 2006 Aug 15;98(6):1681-8.

PMID:
16598774
6.

1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease.

Menaa C, Barsony J, Reddy SV, Cornish J, Cundy T, Roodman GD.

J Bone Miner Res. 2000 Feb;15(2):228-36.

7.

Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone.

Menaa C, Reddy SV, Kurihara N, Maeda H, Anderson D, Cundy T, Cornish J, Singer FR, Bruder JM, Roodman GD.

J Clin Invest. 2000 Jun;105(12):1833-8.

8.

Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone.

Martini G, Gennari L, Merlotti D, Salvadori S, Franci MB, Campagna S, Avanzati A, De Paola V, Valleggi F, Nuti R.

Bone. 2007 Feb;40(2):457-63. Epub 2006 Sep 18.

PMID:
16979395
9.

Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.

Sun SG, Lau YS, Itonaga I, Sabokbar A, Athanasou NA.

J Pathol. 2006 May;209(1):114-20.

PMID:
16482498
10.

NFAM1 signaling enhances osteoclast formation and bone resorption activity in Paget's disease of bone.

Sambandam Y, Sundaram K, Saigusa T, Balasubramanian S, Reddy SV.

Bone. 2017 Aug;101:236-244. doi: 10.1016/j.bone.2017.05.013. Epub 2017 May 12.

11.

STAT-6 mediates TRAIL induced RANK ligand expression in stromal/preosteoblast cells.

Sundaram K, Sambandam Y, Balasubramanian S, Pillai B, Voelkel-Johnson C, Ries WL, Reddy SV.

Bone. 2015 Feb;71:137-44. doi: 10.1016/j.bone.2014.10.016. Epub 2014 Oct 30.

PMID:
25445452
12.

Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget's disease of bone.

Naot D, Bava U, Matthews B, Callon KE, Gamble GD, Black M, Song S, Pitto RP, Cundy T, Cornish J, Reid IR.

J Bone Miner Res. 2007 Feb;22(2):298-309.

13.

Measles virus nucleocapsid protein modulates the Signal Regulatory Protein-╬▓1 (SIRP╬▓1) to enhance osteoclast differentiation in Paget's disease of bone.

Sundaram K, Sambandam Y, Shanmugarajan S, Rao DS, Reddy SV.

Bone Rep. 2016 Jun 14;7:26-32. doi: 10.1016/j.bonr.2016.06.002. eCollection 2017 Dec.

14.
15.

Evaluation of the role of RANK and OPG genes in Paget's disease of bone.

Wuyts W, Van Wesenbeeck L, Morales-Piga A, Ralston S, Hocking L, Vanhoenacker F, Westhovens R, Verbruggen L, Anderson D, Hughes A, Van Hul W.

Bone. 2001 Jan;28(1):104-7.

PMID:
11165949
16.

Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease.

Kurihara N, Reddy SV, Araki N, Ishizuka S, Ozono K, Cornish J, Cundy T, Singer FR, Roodman GD.

J Bone Miner Res. 2004 Jul;19(7):1154-64. Epub 2004 Mar 15.

17.

DACH1 negatively regulates the human RANK ligand gene expression in stromal/preosteoblast cells.

Sundaram K, Mani SK, Kitatani K, Wu K, Pestell RG, Reddy SV.

J Cell Biochem. 2008 Apr 15;103(6):1747-59.

18.

Expression of measles virus nucleocapsid protein in osteoclasts induces Paget's disease-like bone lesions in mice.

Kurihara N, Zhou H, Reddy SV, Garcia Palacios V, Subler MA, Dempster DW, Windle JJ, Roodman GD.

J Bone Miner Res. 2006 Mar;21(3):446-55. Epub 2005 Nov 21.

19.

A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment.

Hiruma Y, Kurihara N, Subler MA, Zhou H, Boykin CS, Zhang H, Ishizuka S, Dempster DW, Roodman GD, Windle JJ.

Hum Mol Genet. 2008 Dec 1;17(23):3708-19. doi: 10.1093/hmg/ddn266. Epub 2008 Sep 2.

20.

Measles virus nucleocapsid protein, a key contributor to Paget's disease, increases IL-6 expression via down-regulation of FoxO3/Sirt1 signaling.

Wang FM, Sarmasik A, Hiruma Y, Sun Q, Sammut B, Windle JJ, Roodman GD, Galson DL.

Bone. 2013 Mar;53(1):269-76. doi: 10.1016/j.bone.2012.12.007. Epub 2012 Dec 20.

Supplemental Content

Support Center